3M Drug Delivery Systems has announced that it is manufacturing the authorized generic of Proventil HFA that was recently launched by Par Pharmaceutical. Proventil HFA, which is also manufactured by 3M, is marketed by Merck. 3M DDS Global Business Leader Keith O-Connor commented, “3M Drug Delivery Systems is proud to work with Par to offer patients a lower list … [Read more...] about 3M announces that it is manufacturing authorized generic of Proventil HFA
Products and Services
Copley Scientific acquires Novi Systems
Inhaler testing equipment company Copley Scientific announced that it has acquired Novi Systems, which manufactures inhaler testing automation solutions, including the Ictus automated Andersen cascade impactor, the Vertus shake, fire and flow control systems, and the Decavertus, which can shake and fire to waste up to ten MDIs at a time. Copley, which recently … [Read more...] about Copley Scientific acquires Novi Systems
Hovione Technology acquires rights to the Papillon DPI
According to Hovione Technology, the company has acquired global development and commercialization rights to the Papillon multi-use dry powder inhaler from its inventor, Klaus-Dieter Beller. The blister-based DPI is reusable and formed from a single part, "enabling ultra-affordable drug therapies at global scale," the company said. The Papillon device will join … [Read more...] about Hovione Technology acquires rights to the Papillon DPI
3M Drug Delivery Systems opens new R&D Inhalation Centre of Excellence
3M Drug Delivery Systems will officially open a new 1,300 sq m R&D Inhalation Centre of Excellence on is Charnwood Campus in Loughborough, UK this month, the company said. According to 3M DDS, the new building, which took 2 years to complete, will house 120 R&D employees. Leicester and Leicestershire Enterprise Partnership Chair Kevin Harris said, “I’m … [Read more...] about 3M Drug Delivery Systems opens new R&D Inhalation Centre of Excellence
Merxin and Perlen Packaging team up to develop cannabis inhalers
Merxin Ltd and Perlen Packaging have announced that they will co-develop inhaled cannabis products based on Perlen’s BLISTair single use dry powder inhaler, with Merxin developing the formulations and marketing the cannabis DPIs. The BLISTair device is completely manufactured on a blister machine, without any molded parts, creating an inhaler from thermoformed … [Read more...] about Merxin and Perlen Packaging team up to develop cannabis inhalers
Orion’s Easyhaler products to connect to Propeller Health inhaler montitoring platform
Orion and Propeller Health have announced that they will co-develop a custom sensor for Orion's Easyhaler devices that will allow the inhalers to connect to Propeller's digital inhaler monitoring platform. According to the companies, "Development of the sensor will begin in 2019, with clinical trials, possible real world evidence projects and a broader commercial … [Read more...] about Orion’s Easyhaler products to connect to Propeller Health inhaler montitoring platform
Senzer inhaler wins second design award
Senzer's Systemic inhaled Delivery Device (SiDD) has won an iF Design Award in the Medicine/Health product category, the company said. The inhaler also recently won a 2018 Good Design award in the medical category. The company is developing several cannabinoid products, including dronabinol and cannabidiol inhalers, based on the breath activated SiDD platform, … [Read more...] about Senzer inhaler wins second design award
Hovione announces that it has issued $50 million bond
CDMO Hovione has announced that it issued a $50 million bond, arranged and subscribed by Banco BPI, that is set to mature in 2033 in order to finance an expansion of its production capacity. The company has previously discussed recently completed and planned expansions of its manufacturing facilities in Portugal, Ireland, and the US, including the addition … [Read more...] about Hovione announces that it has issued $50 million bond
Nanoform announces construction of new GMP manufacturing facility
Finnish nanotechnology company Nanoform has announced construction of a new 600m2 GMP manufacturing facility at Viikki Life Science Park in Helsinki. The plant, which is expected to be operational sometime in 2019, will result in a six-fold increase the company's capacity for nanonization of API for clinical trial use and will add the capability to handle potent APIs. … [Read more...] about Nanoform announces construction of new GMP manufacturing facility
Biocorp and Lindal partner to commercialize Inspair inhaler sensor in several regions
French device company Biocorp announced that it has signed an agreement with Lindal Group subsidiary VARI under which VARI will incorporate Biocorp's Inspair inhaler sensor into its devices in a deal that includes exclusivity for countries in South America, Southeast Asia, Eastern Europe, and the Middle East. Biocorp announced the launch of the Inspair sensor in … [Read more...] about Biocorp and Lindal partner to commercialize Inspair inhaler sensor in several regions